Royal Bank of Canada’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-134
| Closed | – | – | 7321 |
|
2023
Q2 | $0 | Sell |
134
-31
| -19% | – | ﹤0.01% | 7328 |
|
2023
Q1 | $0 | Buy |
165
+82
| +99% | – | ﹤0.01% | 7124 |
|
2022
Q4 | $0 | Sell |
83
-96
| -54% | – | ﹤0.01% | 7416 |
|
2022
Q3 | $1K | Buy |
179
+24
| +15% | +$134 | ﹤0.01% | 6861 |
|
2022
Q2 | $1K | Sell |
155
-666
| -81% | -$4.3K | ﹤0.01% | 6804 |
|
2022
Q1 | $9K | Sell |
821
-1,936
| -70% | -$21.2K | ﹤0.01% | 6533 |
|
2021
Q4 | $53K | Buy |
2,757
+1,279
| +87% | +$24.6K | ﹤0.01% | 5818 |
|
2021
Q3 | $38K | Buy |
1,478
+549
| +59% | +$14.1K | ﹤0.01% | 5811 |
|
2021
Q2 | $21K | Buy |
929
+779
| +519% | +$17.6K | ﹤0.01% | 6045 |
|
2021
Q1 | $4K | Sell |
150
-475
| -76% | -$12.7K | ﹤0.01% | 6623 |
|
2020
Q4 | $11K | Buy |
625
+500
| +400% | +$8.8K | ﹤0.01% | 5790 |
|
2020
Q3 | $2K | Sell |
125
-37
| -23% | -$592 | ﹤0.01% | 5859 |
|
2020
Q2 | $1K | Buy |
162
+6
| +4% | +$37 | ﹤0.01% | 6043 |
|
2020
Q1 | $1K | Buy |
156
+56
| +56% | +$359 | ﹤0.01% | 6033 |
|
2019
Q4 | $1K | Sell |
100
-93
| -48% | -$930 | ﹤0.01% | 6110 |
|
2019
Q3 | $4K | Buy |
193
+18
| +10% | +$373 | ﹤0.01% | 5483 |
|
2019
Q2 | $4K | Hold |
175
| – | – | ﹤0.01% | 5485 |
|
2019
Q1 | $7K | Hold |
175
| – | – | ﹤0.01% | 5233 |
|
2018
Q4 | $8K | Sell |
175
-4
| -2% | -$183 | ﹤0.01% | 5195 |
|
2018
Q3 | $24K | Buy |
179
+127
| +244% | +$17K | ﹤0.01% | 4985 |
|
2018
Q2 | $25K | Buy |
+52
| New | +$25K | ﹤0.01% | 4870 |
|